SSH1 and neoplasm: While SSH-1 expression was significantly associated with higher pathological grade (56.55% vs. 47.17%, p = 0.020), lymphovascular invasion (18.94% vs. 10.94%, p = 0.006), and an increased occurrence of tumor recurrence (56.27% vs. 38.11%, p < 0.001) and progression (45.96% vs. 28.68%, p < 0.001).